Dr. Courtney Jones received her PhD from New York University in 2014 and trained as a postdoctoral fellow at the University of Colorado. Throughout her training, Courtney’s research focused on understanding and targeting acute leukemia cells. She is currently a Scientist at the Princess Margaret Cancer Centre and an Assistant Professor at the University of Toronto. The goal of Dr. Jones’s research is to discovery new ways to target leukemia cells with the overall goal of improving outcomes for patients with leukemia while minimizing side effects. To date, her largest contribution to blood cancer research was the discovery of metabolic vulnerabilities of leukemia cells that have been translated into clinical trials in collaboration with her clinical colleagues. The objective of her current research studies is to discover and develop a new strategy to eradicate leukemia cells in patients for whom standard chemotherapy has failed.